Feature

Video

Sponsored

Capacity and Surge Response Leading Into a State of Readiness

Sustaining pandemic readiness requires investment in workforce, infrastructure, and scalable manufacturing practices.

Declining pandemic readiness is cause for concern; as such, the panelists highlight the importance of maintaining manufacturing capacity, a skilled workforce, and robust health infrastructure. Sustainable practices, including leveraging flu vaccine systems, are recommended for better future preparedness.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.